Doctors vs the FDA: A Supreme Court decision on mail-order Mifepristone – 6/27/24

Dr. Ingrid Skop was interviewed for the Family Life Noon Report, with a pro-life OB-GYN’s perspective on the recent Supreme Court decision saying the “Hippocratic Medicine” group was not the right plaintiff to bring suit against the Federal Food and Drug Administration.

Previous Family Life Interviews:

Attorney Katie Daniel of Susan B. Anthony Prolife America gave us initial reaction to this Supreme Court decision, why the justices’ ruling does not end this issue against the FDA, and what the next steps will be:  6/24/2024

Dr. Ingrid Skop spoke with us, as this case was being decided by the U.S. Court of Appeals:  6/01/2023

Dr. Ingrid Skop, in a Family Life Interview, about the harm many patients are suffering, because of the unchecked side effects of the abortion-triggering drug Mifepristone:  4/25/2023

Family Life’s weekly Pennsylvania and New York roundtable frequently discussed the matters surrounding the prevalence of these abortion pills, increasingly without a doctor’s supervision and care:  scroll through Capital Connection archives